Stimulation of De Novo Pyrimidine Synthesis by Growth Signaling Through MTOR and S6K1

Overview

Journal Science

Specialty Science

Date 2013 Feb 23

PMID 23429703

Citations 409

Authors

Issam Ben-Sahra

Jessica J Howell

John M Asara

Brendan D Manning

Affiliations

Soon will be listed here.

Abstract

Cellular growth signals stimulate anabolic processes. The mechanistic target of rapamycin complex 1 (mTORC1) is a protein kinase that senses growth signals to regulate anabolic growth and proliferation. Activation of mTORC1 led to the acute stimulation of metabolic flux through the de novo pyrimidine synthesis pathway. mTORC1 signaling posttranslationally regulated this metabolic pathway via its downstream target ribosomal protein S6 kinase 1 (S6K1), which directly phosphorylates S1859 on CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, dihydroorotase), the enzyme that catalyzes the first three steps of de novo pyrimidine synthesis. Growth signaling through mTORC1 thus stimulates the production of new nucleotides to accommodate an increase in RNA and DNA synthesis needed for ribosome biogenesis and anabolic growth.

Citing Articles

Succinate dehydrogenase activity supports de novo purine synthesis.

Nengroo M, Klein A, Carr H, Vidal-Cruchez O, Sahu U, McGrail D bioRxiv. 2025; .

PMID: 40060604 PMC: 11888382. DOI: 10.1101/2025.02.26.640389.

Succinate Dehydrogenase loss causes cascading metabolic effects that impair pyrimidine biosynthesis.

Hart M, Davidsen K, Danquah S, Zheng E, Sokolov D, Sullivan L bioRxiv. 2025; .

PMID: 40027747 PMC: 11870577. DOI: 10.1101/2025.02.18.638948.

Erianin inhibits the proliferation of lung cancer cells by suppressing mTOR activation and disrupting pyrimidine metabolism.

Yan L, Liu Y, Huang Y, Sun X, Jiang H, Gu J Cancer Biol Med. 2025; 22(2).

PMID: 39995202 PMC: 11899589. DOI: 10.20892/j.issn.2095-3941.2024.0385.

Uridine Metabolism as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALL.

Liu Y, Jiang H, Liu J, Stuani L, Merchant M, Jager A bioRxiv. 2025; .

PMID: 39975156 PMC: 11838334. DOI: 10.1101/2025.01.27.635108.

Dietary phytochemical indole-3-carbinol regulates metabolic reprogramming in mouse prostate tissue.

Peter R, Sarwar M, Wang L, Chou P, Wang C, Wang Y Pharm Res. 2025; 42(2):237-247.

PMID: 39904853 PMC: 11880055. DOI: 10.1007/s11095-025-03820-8.

References

Pearce L, Alton G, Richter D, Kath J, Lingardo L, Chapman J . Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). Biochem J. 2010; 431(2):245-55. DOI: 10.1042/BJ20101024. View

Yu Y, Yoon S, Poulogiannis G, Yang Q, Ma X, Villen J . Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science. 2011; 332(6035):1322-6. PMC: 3195509. DOI: 10.1126/science.1199484. View

Menon S, Manning B . Common corruption of the mTOR signaling network in human tumors. Oncogene. 2009; 27 Suppl 2:S43-51. PMC: 3752670. DOI: 10.1038/onc.2009.352. View

Dibble C, Asara J, Manning B . Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol Cell Biol. 2009; 29(21):5657-70. PMC: 2772744. DOI: 10.1128/MCB.00735-09. View

Radu A, Neubauer V, Akagi T, Hanafusa H, Georgescu M . PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol Cell Biol. 2003; 23(17):6139-49. PMC: 180959. DOI: 10.1128/MCB.23.17.6139-6149.2003. View

Hsu P, Kang S, Rameseder J, Zhang Y, Ottina K, Lim D . The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science. 2011; 332(6035):1317-22. PMC: 3177140. DOI: 10.1126/science.1199498. View

Duvel K, Yecies J, Menon S, Raman P, Lipovsky A, Souza A . Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010; 39(2):171-83. PMC: 2946786. DOI: 10.1016/j.molcel.2010.06.022. View

Tanti J, Cormont M, Gremeaux T, Le Marchand-Brustel Y . Assays of glucose entry, glucose transporter amount, and translocation. Methods Mol Biol. 2001; 155:157-65. DOI: 10.1385/1-59259-231-7:157. View

Huang J, Manning B . The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008; 412(2):179-90. PMC: 2735030. DOI: 10.1042/BJ20080281. View

10.

Porstmann T, Santos C, Griffiths B, Cully M, Wu M, Leevers S . SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 2008; 8(3):224-36. PMC: 2593919. DOI: 10.1016/j.cmet.2008.07.007. View

11.

Williamson R, Yea C, Robson P, Curnock A, Gadher S, Hambleton A . Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide. Transplant Proc. 1996; 28(6):3088-91. View

12.

Mori M, TATIBANA M . A multienzyme complex of carbamoyl-phosphate synthase (glutamine): aspartate carbamoyltransferase: dihydoorotase (rat ascites hepatoma cells and rat liver). Methods Enzymol. 1978; 51:111-20. DOI: 10.1016/s0076-6879(78)51019-7. View

13.

Laplante M, Sabatini D . mTOR signaling in growth control and disease. Cell. 2012; 149(2):274-93. PMC: 3331679. DOI: 10.1016/j.cell.2012.03.017. View

14.

Alessi D, Caudwell F, Andjelkovic M, Hemmings B, Cohen P . Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 1996; 399(3):333-8. DOI: 10.1016/s0014-5793(96)01370-1. View

15.

Yuan M, Breitkopf S, Yang X, Asara J . A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc. 2012; 7(5):872-81. PMC: 3685491. DOI: 10.1038/nprot.2012.024. View

16.

Iadevaia V, Huo Y, Zhang Z, Foster L, Proud C . Roles of the mammalian target of rapamycin, mTOR, in controlling ribosome biogenesis and protein synthesis. Biochem Soc Trans. 2012; 40(1):168-72. DOI: 10.1042/BST20110682. View

17.

Belin S, Hacot S, Daudignon L, Therizols G, Pourpe S, Mertani H . Purification of ribosomes from human cell lines. Curr Protoc Cell Biol. 2010; Chapter 3:Unit 3.40. DOI: 10.1002/0471143030.cb0340s49. View

18.

Musmanno L, Jamison R, Barnett R, Buford E, Davidson J . Complete hamster CAD protein and the carbamylphosphate synthetase domain of CAD complement mammalian cell mutants defective in de novo pyrimidine biosynthesis. Somat Cell Mol Genet. 1992; 18(4):309-18. DOI: 10.1007/BF01235754. View

19.

Locasale J, Grassian A, Melman T, Lyssiotis C, Mattaini K, Bass A . Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet. 2011; 43(9):869-74. PMC: 3677549. DOI: 10.1038/ng.890. View

20.

Flotow H, Thomas G . Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver. J Biol Chem. 1992; 267(5):3074-8. View